PhD in a medical or health science field related to the reseach speciality which may include Genetics, Genomics, Computer Science, Computational Biology,...
From Marshfield Clinic - Sat, 09 Dec 2017 16:10:40 GMT - View all Marshfield, WI jobs

Notice NOT-HD-17-030 from the NIH Guide for Grants and Contracts

Notice NOT-AG-17-025 from the NIH Guide for Grants and Contracts

Notice NOT-AG-17-026 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-19-013 from the NIH Guide for Grants and Contracts. The purpose of the Funding Opportunity Announcement (FOA) is to encourage research into the role of pluripotent progenitor/stem cells in the pathogenesis and treatment of selected gynecologic disorders, specifically uterine fibroids, endometriosis, adenomyosis, endometrial polyps, and pelvic organ prolapse.

Funding Opportunity PAS-18-483 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research addressing fundamental questions in basic neuroscience. Proposed projects can address any area of neuroscience within the missions of the participating institutes and should focus on understanding the development, the structure and/or the function of the normal nervous system. While fundamental basic research often generates insights relevant to disorders of the nervous system, this FOA is not intended to stimulate research that is explicitly disease-related.

Notice NOT-CA-18-029 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-026 from the NIH Guide for Grants and Contracts

Notice NOT-AR-18-009 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-025 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop models that emulate critical aspects of a human blinding disease that might be amenable to regenerative therapy. The model system might involve specific defects generated by transgenic gene insertion and/or deletion, gene editing, chemical/physical means, and/or other approaches to emulate characteristics of human disease or create defects amenable to cell-replacement therapy. Model systems using non-human primates or other cone-dominant species that are more representative of the anatomy and physiology of the human retina are highly encouraged. Other biological models are acceptable provided they meet the overall objectives of the FOA. An important aspect of this FOA is that the research team is expected to treat the loss of vision associated with the experimental model using an approach that involves regenerating PRCs and/or RGCs and their connections. The choice of cells for therapy might include adult stem cells, precursors, stem cell derived progenitor cells, or conversion of intrinsic cells such as glia. It is expected that quantitative measures will be used to evaluate survival and integration of the regenerated cells using electrophysiology, functional imaging, behavioral measures or any other appropriate technology that would demonstrate circuit integration and restoration of visual function.

Notice NOT-RM-18-002 from the NIH Guide for Grants and Contracts

Notice NOT-RM-18-004 from the NIH Guide for Grants and Contracts

Notice NOT-RM-18-007 from the NIH Guide for Grants and Contracts

Notice NOT-RM-18-006 from the NIH Guide for Grants and Contracts

Notice NOT-RM-18-005 from the NIH Guide for Grants and Contracts

Notice NOT-RM-18-003 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Bioinformatician - Cancer - Barcelona Based in the beautiful city of Barcelona, a brand new opportunity has arisen for a talented Bioinformatician specialising in cancer to join one of the largest and most respected Bioinformatics consultancies in the wo Barcelona, Spain

Funding Opportunity RFA-MD-18-004 from the NIH Guide for Grants and Contracts. This initiative will support health services, intervention, and implementation research to understand and reduce racial/ethnic, geographic, and socioeconomic HIV disparities in US women. Projects may address HIV prevention, screening and diagnosis, and/or treatment. Projects may involve primary data collection and/or secondary analysis of existing data.

Funding Opportunity PAR-18-479 from the NIH Guide for Grants and Contracts. This initiative supports research to test the effectiveness of combined strategies to both detect and intervene to reduce the risk of suicide behavior, suicide ideation, and non-suicidal self-harm (NSSI) by youth in contact with the juvenile justice system. Opportunities for detection and prevention start at early points of contact (e.g., police interaction, the intake interview) and continue through many juvenile justice settings (e.g., pre-trial detention, juvenile or family court activities, court disposition, placement and on-going care in either residential or multiple community settings.) This FOA invites intervention strategies that are designed to be delivered in typical service settings using typically available personnel and resources, to enhance the implementation of interventions that prove effective, enhance their future uptake in diverse settings, and thereby reduce risk of suicide and self-harm in this population. This FOA is published in parallel to a companion R34 FOA (PAR-xx-xxx) supporting pilot studies in preparation for the larger-scale studies described here.